{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:46:00Z","timestamp":1773283560657,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,8,31]],"date-time":"2012-08-31T00:00:00Z","timestamp":1346371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00044-012-0203-y","type":"journal-article","created":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T13:13:15Z","timestamp":1346332395000},"page":"2115-2123","source":"Crossref","is-referenced-by-count":15,"title":["Bioactive xanthones with effect on P-glycoprotein and prediction of intestinal absorption"],"prefix":"10.1007","volume":"22","author":[{"given":"Em\u00edlia","family":"Sousa","sequence":"first","affiliation":[]},{"given":"Andreia","family":"Palmeira","sequence":"additional","affiliation":[]},{"given":"Ana Sara","family":"Cordeiro","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[]},{"given":"Domingos","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Raquel T.","family":"Lima","sequence":"additional","affiliation":[]},{"given":"M.","family":"Helena Vasconcelos","sequence":"additional","affiliation":[]},{"given":"Madalena","family":"Pinto","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,8,31]]},"reference":[{"issue":"1","key":"203_CR1","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1208\/aapsj080101","volume":"8","author":"PV Balimane","year":"2006","unstructured":"Balimane PV, Han YH, Chong S (2006) Current industrial practices of assessing permeability and P-glycoprotein interaction. AAPS J 8(1):E1\u2013E13. doi: 10.1208\/aapsj080101","journal-title":"AAPS J"},{"issue":"5","key":"203_CR2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/med.10015","volume":"22","author":"A Boumendjel","year":"2002","unstructured":"Boumendjel A, Di Pietro A, Dumontet C, Barron D (2002) Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance. Med Res Rev 22(5):512\u2013529. doi: 10.1002\/med.10015","journal-title":"Med Res Rev"},{"issue":"4","key":"203_CR3","first-page":"317","volume":"6","author":"G Camenisch","year":"1998","unstructured":"Camenisch G, Alsenz J, van de Waterbeemd H, Folkers G (1998) Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs\u2019 lipophilicity and molecular weight. Eur J Pharm Sci 6(4):317\u2013324. doi: S0928098797100197 [pii]","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"203_CR4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1359-6446(00)01540-3","volume":"5","author":"PJ Eddershaw","year":"2000","unstructured":"Eddershaw PJ, Beresford AP, Bayliss MK (2000) ADME\/PK as part of a rational approach to drug discovery. Drug Discov Today 5(9):409\u2013414. doi: S1359-6446(00)01540-3 [pii]","journal-title":"Drug Discov Today"},{"issue":"6","key":"203_CR5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0959-8049(96)00047-0","volume":"32A","author":"JM Ford","year":"1996","unstructured":"Ford JM (1996) Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers. Eur J Cancer 32A(6):991\u20131001","journal-title":"Eur J Cancer"},{"issue":"3","key":"203_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/156800909788166493","volume":"9","author":"K Goda","year":"2009","unstructured":"Goda K, Bacso Z, Szabo G (2009) Multidrug resistance through the spectacle of P-glycoprotein. Curr Cancer Drug Targets 9(3):281\u2013297","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"203_CR7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2(1):48\u201358. doi: 10.1038\/nrc706","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"203_CR8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1211\/jpp.57.10.0008","volume":"57","author":"Y He","year":"2005","unstructured":"He Y, Zeng S (2005) Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers. J Pharm Pharmacol 57(10):1297\u20131303. doi: 10.1211\/jpp.57.10.0008","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"203_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2006.10.007","volume":"55","author":"M Hennessy","year":"2007","unstructured":"Hennessy M, Spiers JP (2007) A primer on the mechanics of P-glycoprotein the multidrug transporter. Pharmacol Res 55(1):1\u201315. doi: 10.1016\/j.phrs.2006.10.007 S1043-6618(06)00189-7 [pii]","journal-title":"Pharmacol Res"},{"key":"203_CR10","unstructured":"ICH harmonised tripartite guideline (2005) Validation of analytical procedures: text and methodology Q2(R1). International Conference on Harmonization. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q2_R1\/Step4\/Q2_R1__Guideline.pdf . Accessed 27 August 2012"},{"issue":"12","key":"203_CR11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1359-6446(99)01423-3","volume":"4","author":"D Johnson","year":"1999","unstructured":"Johnson D (1999) The discovery-development interface has become the new interfacial phenomenon. Drug Discov Today 4(12):535\u2013536. doi: S1359-6446(99)01423-3 [pii]","journal-title":"Drug Discov Today"},{"issue":"1","key":"203_CR12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","volume":"455","author":"RL Juliano","year":"1976","unstructured":"Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455(1):152\u2013162. doi: 0005-2736(76)90160-7 [pii]","journal-title":"Biochim Biophys Acta"},{"issue":"22","key":"203_CR13","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1016\/j.bmcl.2005.07.079","volume":"15","author":"IK Kostakis","year":"2005","unstructured":"Kostakis IK, Tenta R, Pouli N, Marakos P, Skaltsounis A-L, Pratsinis H, Kletsas D (2005) Design, synthesis, and antiproliferative activity of some novel aminosubstituted xanthenones, able to overcome multidrug resistance toward MES-SA\/Dx5 cells. Bioorg Med Chem Lett 15(22):5057\u20135060","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"203_CR14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1096\/fasebj.9.8.7768354","volume":"9","author":"E Levy","year":"1995","unstructured":"Levy E, Mehran M, Seidman E (1995) Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. FASEB J 9(8):626\u2013635","journal-title":"FASEB J"},{"issue":"2","key":"203_CR15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0925-4439(97)00027-6","volume":"1361","author":"T Litman","year":"1997","unstructured":"Litman T, Zeuthen T, Skovsgaard T, Stein WD (1997) Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity. Biochim Biophys Acta 1361(2):169\u2013176. doi: S0925-4439(97)00027-6 [pii]","journal-title":"Biochim Biophys Acta"},{"issue":"50","key":"203_CR16","doi-asserted-by":"crossref","first-page":"39272","DOI":"10.1074\/jbc.M007741200","volume":"275","author":"TW Loo","year":"2000","unstructured":"Loo TW, Clarke DM (2000) Identification of residues within the drug-binding domain of the human multidrug resistance P-glycoprotein by cysteine-scanning mutagenesis and reaction with dibromobimane. J Biol Chem 275(50):39272\u201339278. doi: 10.1074\/jbc.M007741200 M007741200 [pii]","journal-title":"J Biol Chem"},{"issue":"2","key":"203_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0960-894X(99)00636-8","volume":"10","author":"M Maitrejean","year":"2000","unstructured":"Maitrejean M, Comte G, Barron D, El Kirat K, Conseil G, Di Pietro A (2000) The flavanolignan silybin and its hemisynthetic derivatives, a novel series of potential modulators of P-glycoprotein. Bioorg Med Chem Lett 10(2):157\u2013160. doi: S0960-894X(99)00636-8 [pii]","journal-title":"Bioorg Med Chem Lett"},{"issue":"1 Suppl","key":"203_CR18","doi-asserted-by":"crossref","first-page":"230S","DOI":"10.1093\/ajcn\/81.1.230S","volume":"81","author":"C Manach","year":"2005","unstructured":"Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81(1 Suppl):230S\u2013242S. doi: 81\/1\/230S [pii]","journal-title":"Am J Clin Nutr"},{"key":"203_CR19","doi-asserted-by":"crossref","unstructured":"Paiva A, Sousa M, Cam\u00f5es A, Nascimento M, Pinto M (2011) Prenylated xanthones: antiproliferative effects and enhancement of the growth inhibitory action of 4-hydroxytamoxifen in estrogen receptor-positive breast cancer cell line. Med Chem Res 1-7. doi: 10.1007\/s00044-011-9562-z","DOI":"10.1007\/s00044-011-9562-z"},{"issue":"1","key":"203_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1747-0285.2010.00978.x","volume":"76","author":"A Palmeira","year":"2010","unstructured":"Palmeira A, Paiva A, Sousa E, Seca H, Almeida GM, Lima RT, Fernandes MX, Pinto M, Vasconcelos MH (2010) Insights into the in vitro antitumor mechanism of action of a new pyranoxanthone. Chem Biol Drug Des 76(1):43\u201358","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"203_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1747-0285.2011.01089.x","volume":"78","author":"A Palmeira","year":"2011","unstructured":"Palmeira A, Rodrigues F, Sousa E, Pinto M, Vasconcelos MH, Fernandes MX (2011) New uses for old drugs: pharmacophore-based screening for the discovery of P-glycoprotein inhibitors. Chem Biol Drug Des 78(1):57\u201372. doi: 10.1111\/j.1747-0285.2011.01089.x","journal-title":"Chem Biol Drug Des"},{"key":"203_CR22","doi-asserted-by":"crossref","unstructured":"Palmeira A, Vasconcelos MH, Paiva A, Fernandes MX, Pinto M, Sousa E (2012) Design of dual inhibitors of P-glycoprotein and tumor cell growth: (re)discovering thioxanthones. Biochem Pharmacol 83:57\u201368. doi: 10.1016\/j.bcp.2011.10.004","DOI":"10.1016\/j.bcp.2011.10.004"},{"issue":"12","key":"203_CR23","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1016\/S0968-0896(02)00379-6","volume":"10","author":"M Pedro","year":"2002","unstructured":"Pedro M, Cerqueira F, Sousa ME, Nascimento MS, Pinto M (2002) Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro. Bioorg Med Chem 10(12):3725\u20133730. doi: S0968089602003796 [pii]","journal-title":"Bioorg Med Chem"},{"issue":"21","key":"203_CR24","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.2174\/092986705774370691","volume":"12","author":"MM Pinto","year":"2005","unstructured":"Pinto MM, Sousa ME, Nascimento MS (2005) Xanthone derivatives: new insights in biological activities. Curr Med Chem 12(21):2517\u20132538","journal-title":"Curr Med Chem"},{"issue":"1","key":"203_CR25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-5793(97)01268-4","volume":"417","author":"B Sankaran","year":"1997","unstructured":"Sankaran B, Bhagat S, Senior AE (1997) Photoaffinity labelling of P-glycoprotein catalytic sites. FEBS Lett 417(1):119\u2013122. doi: S0014-5793(97)01268-4 [pii]","journal-title":"FEBS Lett"},{"issue":"10","key":"203_CR26","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/S0968-0896(02)00169-4","volume":"10","author":"L Saraiva","year":"2002","unstructured":"Saraiva L, Fresco P, Pinto E, Sousa E, Pinto M, Goncalves J (2002) Synthesis and in vivo modulatory activity of protein kinase C of xanthone derivatives. Bioorg Med Chem 10(10):3219\u20133227. doi: S0968089602001694 [pii]","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"203_CR27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/147563601000118400","volume":"18","author":"L Saraiva","year":"2003","unstructured":"Saraiva L, Fresco P, Pinto E, Sousa E, Pinto M, Goncalves J (2003a) Inhibition of alpha, betaI, delta, eta, and zeta protein kinase C isoforms by xanthonolignoids. J Enzyme Inhib Med Chem 18(4):357\u2013370","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"7","key":"203_CR28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0968-0896(02)00641-7","volume":"11","author":"L Saraiva","year":"2003","unstructured":"Saraiva L, Fresco P, Pinto E, Sousa E, Pinto M, Goncalves J (2003b) Inhibition of protein kinase C by synthetic xanthone derivatives. Bioorg Med Chem 11(7):1215\u20131225. doi: S0968089602006417 [pii]","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"203_CR29","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1016\/j.bmc.2008.01.028","volume":"16","author":"H Serra","year":"2008","unstructured":"Serra H, Mendes T, Bronze MR, Simplicio AL (2008) Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones. Bioorg Med Chem 16(7):4009\u20134018. doi: 10.1016\/j.bmc.2008.01.028 S0968-0896(08)00045-X [pii]","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"203_CR30","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1522-2675(200209)85:9<2862::AID-HLCA2862>3.0.CO;2-R","volume":"85","author":"EP Sousa","year":"2002","unstructured":"Sousa EP, Silva AMS, Pinto MMM, Pedro MM, Cerqueira FAM, Nascimento MSJ (2002) Isomeric kielcorins and dihydroxyxanthones: synthesis, structure elucidation, and inhibitory activities of growth of human cancer cell lines and on the proliferation of human lymphocytes in vitro. Helv Chim Acta 85(9):2862\u20132876. doi: 10.1002\/1522-2675(200209)85:9<2862:aid-hlca2862>3.0.co;2-r","journal-title":"Helv Chim Acta"},{"issue":"1","key":"203_CR31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1081\/JLC-120017150","volume":"26","author":"MEl Sousa","year":"2003","unstructured":"Sousa MEl, Afonso CMM, Pinto MMM (2003) Quantitative analysis of kielcorins in biomimetic synthesis by liquid chromatography\/UV detection. J Liq Chromatogr Relat Technol 26(1):29\u201341","journal-title":"J Liq Chromatogr Relat Technol"},{"issue":"9","key":"203_CR32","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1016\/j.ejmech.2009.04.011","volume":"44","author":"E Sousa","year":"2009","unstructured":"Sousa E, Paiva A, Nazareth N, Gales L, Damas AM, Nascimento MSJ, Pinto M (2009) Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure and effect on human tumor cell lines. Eur J Med Chem 44(9):3830\u20133835","journal-title":"Eur J Med Chem"},{"issue":"12","key":"203_CR33","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0960-894X(00)00234-1","volume":"10","author":"DN Tchamo","year":"2000","unstructured":"Tchamo DN, Dijoux-Franca MG, Mariotte AM, Tsamo E, Daskiewicz JB, Bayet C, Barron D, Conseil G, Di Pietro A (2000) Prenylated xanthones as potential P-glycoprotein modulators. Bioorg Med Chem Lett 10(12):1343\u20131345. doi: S0960-894X(00)00234-1 [pii]","journal-title":"Bioorg Med Chem Lett"},{"key":"203_CR34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/chromsci\/46.6.472","volume":"46","author":"M Teixeira","year":"2008","unstructured":"Teixeira M, Afonso CMM, Pinto MM, Barbosa CM (2008) Development and validation of an HPLC method for the quantitation of 1,3-dihydroxy-2-methylxanthone in biodegradable nanoparticles. J Chromatogr Sci 46:472\u2013478","journal-title":"J Chromatogr Sci"},{"key":"203_CR35","unstructured":"US Pharmacopoeia 24\/National Formulary 19, United States Pharmacopeial Convention (1995), vol p.2149, section\u00a01225. Rockville"},{"issue":"5","key":"203_CR36","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0090-9556(24)15095-7","volume":"28","author":"EJ Wang","year":"2000","unstructured":"Wang EJ, Casciano CN, Clement RP, Johnson WW (2000) In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein. Drug Metab Dispos 28(5):522\u2013528","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"203_CR37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","volume":"10","author":"S Yamashita","year":"2000","unstructured":"Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H, Tokuda H (2000) Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci 10(3):195\u2013204. doi: S0928-0987(00)00076-2 [pii]","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"203_CR38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchromb.2004.06.009","volume":"809","author":"S Zhou","year":"2004","unstructured":"Zhou S, Feng X, Kestell P, Baguley BC, Paxton JW (2004) Determination of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide in Caco-2 monolayers by liquid chromatography with fluorescence detection: application to transport studies. J Chromatogr B Analyt Technol Biomed Life Sci 809(1):87\u201397. doi: 10.1016\/j.jchromb.2004.06.009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-012-0203-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00044-012-0203-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-012-0203-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T14:38:08Z","timestamp":1744036688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00044-012-0203-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,31]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["203"],"URL":"https:\/\/doi.org\/10.1007\/s00044-012-0203-y","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,31]]}}}